Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Research & Development (2016 - 2025)

Historic Research & Development for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $338000.0.

  • Nephros' Research & Development rose 7978.72% to $338000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 3874.71%. This contributed to the annual value of $906000.0 for FY2024, which is 378.01% up from last year.
  • Nephros' Research & Development amounted to $338000.0 in Q3 2025, which was up 7978.72% from $311000.0 recorded in Q2 2025.
  • In the past 5 years, Nephros' Research & Development ranged from a high of $556000.0 in Q1 2021 and a low of $188000.0 during Q3 2024
  • Its 5-year average for Research & Development is $302368.4, with a median of $273000.0 in 2022.
  • As far as peak fluctuations go, Nephros' Research & Development plummeted by 4740.35% in 2021, and later surged by 7978.72% in 2025.
  • Nephros' Research & Development (Quarter) stood at $328000.0 in 2021, then rose by 9.45% to $359000.0 in 2022, then plummeted by 42.06% to $208000.0 in 2023, then increased by 21.15% to $252000.0 in 2024, then skyrocketed by 34.13% to $338000.0 in 2025.
  • Its last three reported values are $338000.0 in Q3 2025, $311000.0 for Q2 2025, and $295000.0 during Q1 2025.